California State Teachers Retirement System (CalSTRS)’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$673K Sell
39,583
-1,178
-3% -$19.5K ﹤0.01% 2087
2026
Q1
$662K Buy
40,761
+38,431
+1,649% +$680K ﹤0.01% 1963
2025
Q4
$43.6K Sell
2,330
-332
-12% -$5.51K ﹤0.01% 2311
2025
Q3
$38.9K Buy
2,662
+1
+0% +$13 ﹤0.01% 2332
2025
Q2
$29.4K Hold
2,661
﹤0.01% 2385
2025
Q1
$23.8K Sell
2,661
-31,672
-92% -$295K ﹤0.01% 2477
2024
Q4
$323K Sell
34,333
-170
-0.5% -$1.55K ﹤0.01% 2273
2024
Q3
$278K Sell
34,503
-1,045
-3% -$9.05K ﹤0.01% 2320
2024
Q2
$301K Sell
35,548
-2,906
-8% -$26.2K ﹤0.01% 2299
2024
Q1
$345K Sell
38,454
-7,930
-17% -$73.5K ﹤0.01% 2316
2023
Q4
$521K Sell
46,384
-9,632
-17% -$96.9K ﹤0.01% 2187
2023
Q3
$483K Sell
56,016
-8,994
-14% -$86.8K ﹤0.01% 2214
2023
Q2
$673K Sell
65,010
-3,654
-5% -$40.3K ﹤0.01% 2146
2023
Q1
$745K Sell
68,664
-7,195
-9% -$76.1K ﹤0.01% 2076
2022
Q4
$851K Buy
75,859
+1,325
+2% +$13.9K ﹤0.01% 2011
2022
Q3
$756K Sell
74,534
-808
-1% -$7.57K ﹤0.01% 2084
2022
Q2
$683K Buy
75,342
+2,184
+3% +$20.1K ﹤0.01% 2197
2022
Q1
$699K Sell
73,158
-5,896
-7% -$57.8K ﹤0.01% 2235
2021
Q4
$874K Buy
79,054
+3,614
+5% +$31.5K ﹤0.01% 2248
2021
Q3
$558K Buy
75,440
+1,983
+3% +$22.2K ﹤0.01% 2433
2021
Q2
$1.07M Buy
73,457
+3,116
+4% +$58.5K ﹤0.01% 2170
2021
Q1
$1.44M Sell
70,341
-212
-0.3% -$4.03K ﹤0.01% 1916
2020
Q4
$1.25M Buy
70,553
+1,006
+1% +$18.1K ﹤0.01% 1899
2020
Q3
$1.03M Buy
69,547
+196
+0.3% +$3.67K ﹤0.01% 1850
2020
Q2
$1.46M Sell
69,351
-5,191
-7% -$133K ﹤0.01% 1651
2020
Q1
$1.72M Buy
74,542
+5,636
+8% +$141K ﹤0.01% 1390
2019
Q4
$1.78M Hold
68,906
﹤0.01% 1640
2019
Q3
$1.34M Buy
68,906
+823
+1% +$16.6K ﹤0.01% 1750
2019
Q2
$1.11M Buy
68,083
+1,321
+2% +$26.8K ﹤0.01% 1905
2019
Q1
$1.51M Sell
66,762
-989
-1% -$25.1K ﹤0.01% 1697
2018
Q4
$1.73M Buy
67,751
+2,194
+3% +$59.2K ﹤0.01% 1562
2018
Q3
$2.14M Sell
65,557
-24
-0% -$654 ﹤0.01% 1580
2018
Q2
$1.49M Buy
65,581
+1,091
+2% +$25.9K ﹤0.01% 1795
2018
Q1
$1.56M Sell
64,490
-1,345
-2% -$36.9K ﹤0.01% 1686
2017
Q4
$1.84M Sell
65,835
-1,016
-2% -$30.1K ﹤0.01% 1628
2017
Q3
$2.29M Sell
66,851
-7,161
-10% -$234K 0.01% 1483
2017
Q2
$2.95M Sell
74,012
-5,049
-6% -$194K 0.01% 1367
2017
Q1
$2.91M Sell
79,061
-3,700
-4% -$118K 0.01% 1405
2016
Q4
$2.64M Buy
82,761
+5,900
+8% +$183K 0.01% 1483
2016
Q3
$2.79M Buy
76,861
+800
+1% +$22.3K 0.01% 1444
2016
Q2
$1.73M Buy
76,061
+15,542
+26% +$336K ﹤0.01% 1711
2016
Q1
$1.14M Buy
60,519
+7,575
+14% +$124K ﹤0.01% 1945
2015
Q4
$868K Buy
52,944
+6,568
+14% +$104K ﹤0.01% 2080
2015
Q3
$510K Sell
46,376
-200
-0.4% -$2.55K ﹤0.01% 2408
2015
Q2
$606K Buy
46,576
+3,610
+8% +$56K ﹤0.01% 2432
2015
Q1
$745K Sell
42,966
-700
-2% -$12.8K ﹤0.01% 2201
2014
Q4
$651K Buy
43,666
+186
+0.4% +$3.24K ﹤0.01% 2326
2014
Q3
$1M Buy
43,480
+547
+1% +$15.9K ﹤0.01% 2004
2014
Q2
$1.37M Buy
+42,933
New +$1.29M ﹤0.01% 1856

Other funds holding TBPH

California State Teachers Retirement System (CalSTRS)'s TBPH Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Theravance Biopharma (TBPH) stake by 2.9% in Q2 2026, selling an estimated $19.5K and leaving 39,583 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

California State Teachers Retirement System (CalSTRS) first reported a position in TBPH in Q2 2014 and has held it in 49 quarters since. The position peaked at $2.95M in Q2 2017. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 39,583 shares of Theravance Biopharma worth $673K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,178 Theravance Biopharma shares in Q2 2026, an estimated $19.5K.
  • Theravance Biopharma made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2087 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Theravance Biopharma in Q2 2014 and has held it in 49 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Theravance Biopharma position peaked at $2.95M in Q2 2017.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.